It has been concluded by Terlizzi et al. that the caspase-4 positive subpopulation of NSCLC patients is characterized by a specific lipidomic profile associated with alternative pathways, which guarantee glucose metabolism in favor of tumor cell proliferation [18]. The gene discussed is CASP4; the disease is non-small cell lung carcinoma.